BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 12223954)

  • 1. [Vogt-Koyanagi-Harada syndrome in children].
    Laghmari M; Karim A; Ibrahimy W; Essakalli NH; Mohcine Z
    J Fr Ophtalmol; 2002 Jun; 25(6):636-40. PubMed ID: 12223954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Vogt-Koyanagi-Harada syndrome in 11-year-old girl].
    Swiech-Zubilewicz A; Wróblewska E; Mańkowska A
    Klin Oczna; 2005; 107(7-9):511-4. PubMed ID: 16417010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vogt Koyanagi Harada syndrome in children: diagnosis and management].
    Benfdil N; Baha Ali T; Jellab B; Moutaouakil A
    Bull Soc Belge Ophtalmol; 2010; (314):15-8. PubMed ID: 20480746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vogt-Koyanagi-Harada syndrome in a 10-year-old child.
    Ghosh AK; Bhaduri G; Deb A; Singh M; Das K
    J Indian Med Assoc; 2007 Apr; 105(4):210, 212. PubMed ID: 17822191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
    Vukojević M; Vukojevic N; Vuković A; Rupčić B; Blažević M; Blažević A
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):229-231. PubMed ID: 38651852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vogt-Koyanagi-Harada syndrome: a serious and rare emergency in children].
    Venaille A; Palombi K; Templier I; Bouillet L; Pagnier A; Debillon T; Bourdat-Michel G
    Arch Pediatr; 2011 Jan; 18(1):33-6. PubMed ID: 21055910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
    Martin TD; Rathinam SR; Cunningham ET
    Retina; 2010; 30(7):1113-21. PubMed ID: 20168275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vogt-Koyanagi-Harada syndrome in a 4-year old child.
    Cunningham ET; Demetrius R; Frieden IJ; Emery HM; Irvine AR; Good WV
    Am J Ophthalmol; 1995 Nov; 120(5):675-7. PubMed ID: 7485374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation.
    Keino H; Goto H; Usui M
    Graefes Arch Clin Exp Ophthalmol; 2002 Oct; 240(10):878-82. PubMed ID: 12397437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rare form of uveitis with neurological symptoms: the Vogt-Koyanagi-Harada uveomeningoencephalitic syndrome].
    Kätterer C; Kaeser HE; Steiger U
    Schweiz Med Wochenschr; 1992 Feb; 122(8):269-74. PubMed ID: 1542780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Vogt-Koyanagi-Harada syndrome: a rare differential diagnosis of uveitis in childhood. A case report taking into account the revised diagnostic criteria].
    Rieger R; Keitzer R; Pleyer U
    Klin Monbl Augenheilkd; 2005 Nov; 222(11):919-22. PubMed ID: 16308827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
    Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vogt-Koyanagi-Harada disease].
    Kjeka O; Krohn J
    Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2195-7. PubMed ID: 16138134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vogt-Koyanagi-Harada's disease: 3 cases].
    Mikou O; Chiheb S; Zouhair K; Jarmouni RI; Nejjam F; El Ouazzani T; Amraoui A; Lakhdar H
    Ann Dermatol Venereol; 2000 Mar; 127(3):282-4. PubMed ID: 10804302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of Vogt-Koyanagi-Harada syndrome.
    Hettler DL; Levinson JB
    J Am Optom Assoc; 1992 Feb; 63(2):90-4. PubMed ID: 1583270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vogt-koyanagi-harada syndrome.
    Fang W; Yang P
    Curr Eye Res; 2008 Jul; 33(7):517-23. PubMed ID: 18600484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vogt-Koyanagi-Harada syndrome: importance of rapid diagnosis and therapeutic intervention].
    Bouchenaki N; Morisod L; Herbort CP
    Klin Monbl Augenheilkd; 2000 May; 216(5):290-4. PubMed ID: 10863695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vogt-Koyanagi-Harada disease.
    O'Keefe GA; Rao NA
    Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease.
    Read RW; Yu F; Accorinti M; Bodaghi B; Chee SP; Fardeau C; Goto H; Holland GN; Kawashima H; Kojima E; Lehoang P; Lemaitre C; Okada AA; Pivetti-Pezzi P; Secchi A; See RF; Tabbara KF; Usui M; Rao NA
    Am J Ophthalmol; 2006 Jul; 142(1):119-24. PubMed ID: 16815259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.
    Agarwal M; Ganesh SK; Biswas J
    Ocul Immunol Inflamm; 2006 Dec; 14(6):333-9. PubMed ID: 17162603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.